Hospitals

• Medicine-Pediatrics Homepage
• Application Requirements
• Program Information
• Our Residents
• Our Faculty
• Our Hospitals
  • Texas Medical Center
  • Memorial Hermann Hospital
  • Children's Memorial Hermann Hospital
  • Lyndon B. Johnson General Hospital
  • M.D. Anderson Cancer Center
• Stipends and Benefits
• Social Events
• FAQ
• Houston
• Contact Us

M.D. Anderson Cancer Center

The M.D. Anderson Cancer Center (MDACC), established in 1941 to serve Texans with cancer, is part of The University of Texas System and was the first member institution of the Texas Medical Center. It was named after Monroe D. Anderson, a wealthy cotton broker who created a foundation to help institutions foster patient care and dissemination of knowledge. The activities of the MDACC in cancer care, research and education of health care professionals and the public are recognized worldwide. This referral center attracts patients from Texas and around the world. The MDACC has more than 400 faculty. There are strong support services for the diagnosis, treatment, and care of patients with cancer and related disorders. There are more than 500 inpatient beds, including laminar flow rooms and medical and surgical intensive care units. Each year there are more than 17,000 inpatients admitted and more than 500,000 outpatient visits. A new 726,000 square foot patient care and research complex opened in 1999.

Educational activities at the MDACC are integrated with those at the Medical School. The Division of Medicine at MDACC has sections of cardiology, hematology, gastroenterology, endocrinology, infectious diseases, and immunology. Students, house officers, and fellows participate on inpatient, consultive, and ambulatory teaching services staffed by members of the M.D. Anderson and UT Medical School faculties. The emergency center and ambulatory center are staffed by internists who trained at UT-HMS.

At MDACC, residents attend daily morning report, as well as subspecialty conferences. For some conferences house staff and students return to the medical school, just a short minute walk down the block.

At MDACC, more than 400 controlled clinical trials are in progress. Areas of active clinical investigation include chemotherapy, immunotherapy, and new modes of drug delivery.